IFNG and renal cell carcinoma: It has also been reported that after undergoing primary tumor excision and/or immunotherapy and presenting a disease-free period, IFNγ-producing type-1 CD4+ T cells prevail in RCC patients, suggesting that tumor environment may promote a type-2 response [6].